Brief: AB Science To Present Latest Clinical Data On ALS At 2021 Symposium
02/09/2021 17:07
Sept 2 (Reuters) - AB Science SA ABS.PA :
* AB SCIENCE ANNOUNCED TODAY THAT LATEST CLINICAL DATA ON
LONG-TERM SURVIVAL ANALYSES IN ALS WILL BE PRESENTED AT THE 2021
SYMPOSIUM ON ALS/MND
Source text for Eikon: ID:nGNX1cJ0jf
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AB Science SA
See all newsBrief: AB Science Expects To Resume AB8939 Phase 1 In Q1 2027 And Masitinib Phase 3 In Q4 2027
Brief: AB Science Discontinues Phase 2 AB20006, Phase 3 AB15003, Phase 3 AB20009 Studies
Brief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041